Clinical Drug Experience Knowledgebase

abemaciclib (verzenio) (1 trial)

anastrozole (arimidex) (1 trial)

atezolizumab (Tecentriq) (3 trials)

balixafortide (1 trial)

bevacizumab (avastin) (2 trials)

capecitabine (xeloda) (2 trials)

carboplatin (paraplatin) (1 trial)

cb-103 (1 trial)

cobimetinib (cotellic) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

doxorubicin (Doxil) (2 trials)

enzalutamide (xtandi) (1 trial)

eribulin (halaven) (5 trials)

exemestane (aromasin) (1 trial)

fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)

Filgrastim (neupogen) (1 trial)

fulvestrant (faslodex) (3 trials)

gemcitabine (gemzar) (1 trial)

Giredestrant (1 trial)

incmga00012 (1 trial)

ipatasertib (3 trials)

irinotecan (Camptosar) (1 trial)

lenvatinib (lenvima) (1 trial)

letrozole (femara) (4 trials)

loperamide (imodium) (1 trial)

lurbinectedin (Zepzelca) (1 trial)

margetuximab (Margenza) (1 trial)

niraparib (zejula) (1 trial)

olaparib (lynparza) (3 trials)

osimertinib (tagrisso) (1 trial)

paclitaxel (taxol) (4 trials)

palbociclib (ibrance) (3 trials)

pembrolizumab (keytruda) (4 trials)

pertuzumab (perjeta) (2 trials)

radium-223 (xofigo) (1 trial)

sacituzumab govitecan (Trodelvy) (1 trial)

talazoparib (talzenna) (1 trial)

tamoxifen (nolvadex) (3 trials)

temsirolimus (torisel) (1 trial)

tocilizumab (actemra) (1 trial)

trastuzumab (herceptin) (3 trials)

tucatinib (Tukysa) (1 trial)